# EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

> **NCT07448376** · — · NOT_YET_RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 20 (estimated)

## Conditions studied

- CTCs
- Pancreatic Cancer
- Liver Metastases
- Relapse
- Borderline Resectable Pancreatic Cancer
- Resectable Pancreatic Cancers
- EUS

## Interventions

- **DIAGNOSTIC_TEST:** CTC

## Key facts

- **NCT ID:** NCT07448376
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448376, "EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07448376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*